Search
 
Company

JANSSEN PHARMACEUTICALS (Johnson & Johnson)

67 Case(s) (Last 5 Years)

Patents Prosecuted

Application numberTitle of the patentIPCFiling DateDecision Date
17318616 ExPEC glycoconjugate vaccine formulations C08B, A61K May 11, 2021 Dec 18, 2023
17317279 SARS-CoV-2 Vaccines C07K, A61K May 10, 2021
17317322 RNA Replicon Encoding a Stabilized Corona Virus Spike Protein A61P, C07K, C12N, A61K May 10, 2021
17998202 TREATMENTS OF PROSTATE CANCER WITH COMBINATIONS OF ABIRATERONE ACETATE AND NIRAPARIB A61P, A61K May 6, 2021
17314281 Dosing regimens associated with extended release paliperidone injectable formulations A61P, A01N, A61K May 6, 2021 May 9, 2022
17314330 Dosing regimens associated with extended release paliperidone injectable formulations A61P, A61K May 6, 2021 Apr 18, 2022
17998198 TREATMENT OF PROSTATE CANCER WITH A COMBINATION OF ABIRATERONE ACETATE AND NIRAPARIB A61K, A61P May 6, 2021
17998204 PHARMACEUTICAL FORMULATIONS OF ABIRATERONE ACETATE AND NIRAPARIB A61P, A61K May 6, 2021
17314245 Dosing regimens associated with extended release paliperidone injectable formulations A61P, A61K May 6, 2021 Sep 12, 2022
17246184 TAU PET IMAGING LIGANDS C07B, A61K, C07D Apr 29, 2021 Sep 7, 2023
17997135 NEW TRIAZINOINDOLE COMPOUNDS C07D, A61K Apr 28, 2021
17240192 Devices and Methods for Drug Administration and Mixing, and Training of Proper Techniques Therefor A61J, G09B, A61M Apr 25, 2021 Oct 26, 2023
17240648 METHOD FOR IDENTIFICATION AND QUANTIFICATION OF POLYSACCHARIDES IN COMPLEX GLYCOCONJUGATE COMPOSITIONS G01N Apr 25, 2021
17996633 TRICYCLIC COMPOUNDS AS INHIBITORS OF NLRP3 C07D Apr 22, 2021
17995756 RSV INHIBITING 3-SUBSTITUTED QUINOLINE AND CINNOLINE DERIVATIVES A61K, A61P, C07D Apr 20, 2021
17996023 PYRROLO[1,2-D][1,2,4]TRIAZINE-2-YL-ACETAMIDES AS INHIBITORS OF THE NLRP3 INFLAMMASOME PATHWAY C07D Apr 14, 2021
17996090 PYRAZOLO[1,5-D][1,2,4]TRIAZINE-5(4H)-ACETAMIDES AS INHIBITORS OF THE NLRP3 INFLAMMASOME A61K, C07F, C07D Apr 14, 2021
17995945 ALKYNYL NUCLEOSIDE ANALOGS FOR TREATMENT OF HEPATITIS E A61P, A61K Apr 12, 2021
17995948 SPIROCYCLIC NUCLEOSIDE ANALOGUES FOR THE TREATMENT OF HEPATITIS E A61P, A61K Apr 12, 2021
17996083 BI- AND MONOCYCLIC NUCLEOSIDE ANALOGS FOR TREATMENT OF HEPATITIS E A61P, A61K Apr 12, 2021
Menu